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on the forests, wildlife, and
indigenous people of this
area, WWF warns. It is not
necessary to use this area as
there is already a total of
2.3 million hectares of idle or
derelict land available for
palm oil plantations in
Kalimantan, an area greater
than the proposed plantation,
WWF points out.
In addition, oil palm is not
recommended for planting in
areas more than 200 metres
above sea level, because of
low productivity at these
levels. The plantations are
also recommended to be
restricted to areas with an
incline of less than 30 per
cent. But most of the heart of
Borneo border area is
between 1,000 and 2,000
metres high, with infertile,
shallow soils and steep
slopes. Such rugged terrain
means that the risk of erosion
is high.
WWF explains that
“although it makes little
economic sense to plant palm
oil in the uplands, the
plantation companies would
have access to timber, which
they would fell and sell as
part of the plantation
preparation process. This
could be extremely lucrative
and there is evidence that
some companies have
applied for palm oil plantation
licences in the past with this
in mind.”
Malaysia’s oil palm
plantations cover 40 per cent
of its cultivated land and it is
the world’s largest producer
and exporter of palm oil and
Indonesia has also embarked
on a major plantation
programme. Despite the
Indonesian government’s
assurance that the project
would not harm the
environment, WWF insists
that development of palm oil
plantations should follow
strict sustainable and
environmental principles
which exclude the destruction
of forests of high social and
biological importance.Quick guide
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What is spliced leader (SL)
trans-splicing? It is an mRNA
maturation process, similar to
intron splicing, which has been
shown to occur in a limited
number of eukaryotes. In SL
trans-splicing, the cell replaces
nucleotides at the 5′ end of some
pre-mRNAs with those of a
special class of small nuclear
RNAs, called SL RNAs. These are
short molecules with two
functionally distinct halves: the 5′
half consists of the leader
sequence that is transferred to a
pre-mRNA, along with the SL
RNA’s methylguanosine cap; the
3′ half contains a binding site for
the Sm protein complex, which
binds many of the RNAs involved
in intron splicing. These two
halves are separated by a splice
donor site, a GT dinucleotide.
Nuclear machinery trans-splices
the leader sequence to splice
acceptor sites (AG dinucleotides)in the 5′ region of target pre-
mRNAs. As a result, many
mRNAs in SL trans-splicing
species have a common
sequence at the 5′ end. 
How is SL trans-splicing
related to intron splicing? The
mechanism of SL trans-splicing is
very similar to cis- (intron) splicing
(Figure 1). In both cases, the 2′
hydroxyl group of a nucleotide
(usually adenosine) severs the
pre-mRNA backbone at the splice
donor site, freeing the upstream
exon to displace the intron
sequence at the splice acceptor.
In intron splicing, the splice donor
and acceptor sites lie on the same
strand of RNA, separated by the
intron sequence, which contains
the branch point adenosine. For
SL trans-splicing, the splice donor
site of the SL RNA is attacked by
an adenosine between the 5′ end
of the pre-mRNA and its SL
addition site. The region of the
pre-mRNA upstream of the SL
addition site, which is removed
when the leader sequence is
attached, is known as the ‘outron’
— it is ‘outside’ the gene, whereas
introns are ‘inside’.
Strikingly, experiments in the
nematode Caenorhabditis elegans
demonstrated that the relative
location of the donor and
acceptor sites is sufficient to
determine whether a spliceFigure 1. The leader sequence (yellow box) of an SL RNA is attached to the first exon
(orange box) of a pre-mRNA by a trans-splicing reaction. 
The outron of the pre-mRNA and the intron-like portion of the SL RNA form a ‘Y’
branched byproduct, similar to the lariat structure formed during intron splicing. The
2,2,7-trimethylguanosine cap structure (or ‘Cap 4’ in trypanosomes) found on SL RNAs
and trans-spliced mRNAs (blue circles) differs from the 7-methylguanosine caps typi-
cally found on mRNAs (red circles). These caps impart novel properties to trans-spliced
messages.
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Media review 
Aliens — as we
know them
Florian Maderspacher
Alien Worlds —
Big Wave productions.
(Catalogue: C4DVD10020;
Barcode: 6867441002093)
Utopias feature in art and literature
of all ages — from Plato’s Atlantis
and Swift’s lilliput down to modern
science fiction writers like
Stanislaw Lem or Isaac Asimov.
Utopias have always been
employed as a setting in which to
explore what is possible and how
things could be better — or worse.
The recent TV programme, Alien
Worlds — broadcast on Channel 4
in the UK and available
internationally on DVD — attempts
at creating an utopian setting to
address one central question
about the evolution of life on
Earth: is life and the shapes it
comes in a product of mere
coincidence or did it have to come
like this? Was the evolution of life
forms and ultimately of intelligence
chance or necessity?
Many an academic debate has
been fought over this and Alien
Worlds tackles the issue by
envisioning two planets, a mere
50 light years away, that have
evolved life. Planet Aurelia orbits a
red dwarf star and has ceased
rotating, so that one side
experiences never-ending daylight
while the other is in constant
night; where the two sides meet
the ice cap offers a truly
spectacular view from space. The
other world is a marvellous Blue
Moon, which orbits a Saturn-like
gas giant planet that in turn orbits
a double star system.
These worlds differ from places
conjured up by the average
science fiction programme,
because they are scientifically
thought through. The
programme’s producers have
gathered together a team of
astronomers, climatologists and
biologists to put the features of
the planets and their inhabitantsacceptor is cis- or trans-spliced.
Cis-spliced acceptors can be
converted to trans-splicing
acceptors if the donor site
upstream is mutated, and similarly
an SL addition site will be cis-
spliced if a donor site is inserted
upstream. 
What is the function of SL
trans-splicing? SL addition
provides the cell with an
alternative way of capping
mRNAs, a modification required
for mRNA stability, transport and
translation. The standard capping
machinery is typically recruited by
RNA polymerase II at the
beginning of transcription to cap
the growing RNA. In
trypanosomes, SL addition is used
to cap a subset of pre-mRNAs
transcribed by RNA polymerase I,
which does not recruit the capping
machinery. In a wider range of
eukaryotes, SL addition allows the
formation of operons — adjacent
genes that are transcribed as a
single primary transcript. The
cleavage reaction that precedes
polyadenylation of each gene
effectively chops the transcript
into smaller pieces. Since only the
message from the 5′ end retains
the transcript’s original cap, SL
trans-splicing is needed to cap the
remaining fragments. 
Addition of an SL has also been
shown to affect the translation rate
of some genes, add missing start
codons and trim off outron
sequences.  But while the role of
SL addition in these processes is
well established, the benefit of
transcription by polymerase I,
inclusion in an operon, translational
regulation, substitution of a start
codon and outron removal is not
immediately obvious for most
trans-spliced genes. 
How is it phylogenetically
distributed? The complete
phylogenetic distribution of SL
trans-splicing is not currently
known. To date, SL trans-splicing
has been found in six diverse
groups of eukaryotes: nematodes,
flatworms, cnidarians, ascidians,
rotifers and euglenozoans. But it
has not been detected in other
well-studied eukaryotic taxa, such
as fungi, plants, vertebrates and
arthropods.How did it evolve? There are two
competing hypotheses describing
the origin of SL trans-splicing. The
‘SL trans-splicing early’
hypothesis proposes that SL
trans-splicing was present in the
ancestral eukaryote and
subsequently lost in most phyla.
This hypothesis is supported in
part by the continuing discovery
of SL trans-splicing in an
expanding range of eukaryotes.
The ‘SL trans-splicing late’
hypothesis proposes that the
process has emerged several
times independently, and that
features unique to SL addition —
the SL RNA, trans-spliceosome-
specific proteins, SL-specific
translation enhancer proteins,
operons, and so on — are also
independently derived in these
lineages. This hypothesis is
supported by the observation that
the few unique components
shown to be involved in SL
addition are not obviously
conserved across different trans-
splicing phyla. Further studies into
the mechanism and effects of SL
trans-splicing in different phyla
will help to clarify its origin.  
Why should I care? Many of the
organisms that perform SL trans-
splicing, such as trypanosomes,
flatworms and nematodes are
pathogenic to humans. Drugs
that target components of the
trans-spliceosome or disrupt the
downstream effects of SL trans-
splicing may be highly effective
against these parasitic species,
while causing little harm to
patients. 
Where can I find out more?
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